Regeneron Announces Upcoming 2013 Investor Conference Presentations PR Newswire TARRYTOWN, N.Y., Feb. 19, 2013 TARRYTOWN,N.Y., Feb. 19, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: oCiti 2013 Global Healthcare Conference; Dyslipidemia Panel on Tuesday, February 26, 2013. The session is scheduled for 1:30 p.m. Eastern Time. oRBC Capital Markets' 2013 Global Healthcare Conference on Wednesday, February 27, 2013. The presentation is scheduled for 9:30 a.m. Eastern Time. oBarclays Global Healthcare Conference on Tuesday, March 12, 2013. The presentation is scheduled for 2:30 p.m. Eastern Time. The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentations will be available for 30 days. About Regeneron Pharmaceuticals, Inc. Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, and asthma. For additional information about the company, please visit www.regeneron.com. Contact Information: Michael Aberman, M.D. Peter Dworkin Investor Relations Corporate Communications 914.847.7799 914.847.7640 email@example.com firstname.lastname@example.org SOURCE Regeneron Pharmaceuticals, Inc. Website: http://www.regeneron.com
Regeneron Announces Upcoming 2013 Investor Conference Presentations
Press spacebar to pause and continue. Press esc to stop.